Clenbuterol for ALS: Findings from an Open Label Trial @EverythingALS
Clenbuterol for ALS: Findings from an Open Label Trial  @EverythingALS
Uploaded September 2021 | Updated November 2026, 1 day ago
Register to upcoming events
everythingals.org/events

Participate in our ALS Research
everythingals.org/research

Clenbuterol for ALS, Findings from an Open Label Trial with Dr. Richard Bedlack from Duke University.

Richard Bedlack M.D., Ph.D. is currently a Professor of Neurology at Duke University, and Director of the Duke ALS Clinic. He has won awards for teaching and for patient care, including: best neurology teacher at Duke; Health Care Hero; Strength, Hope, and Caring Award; America’s Best Doctors; the American Academy of Neurology's Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award, and the ALS Association's Rasmussen Award for ALS Patient Advocate of the Year.

Dr. Bedkack has also received research grants, participated in clinical trials, and published more than 130 articles. He currently leads the international ALSUntangled program, which utilizes social networking to investigate alternative and off-label treatment options for patients with ALS, and the ALS Reversals program which seeks to verify and understand cases of recovery from ALS in hopes of making them happen more often.

DO NOT Miss Another Event, Subscribe to our Channel:
youtube.com/c/everythingals
Clenbuterol for ALS: Findings from an Open Label TrialImplantable BCI Technology - The Road to Access by Precision Neuroscience, Blackrock and CognixionStories and Innovation in ALS Episode #11:  Dying Out Loud with Dave Warnock and Bevin Jett2025: New therapies and approaches in ALS : gene, small molecules, repair, and moreDr. Olga Uspenskaya-Cadoz and Dr. James Berry discuss PIONEER-ALS and TDP-43 research.Health Insurers Delay or Deny Home Ventilation. What Can Be Done? by Dr. John Hansen-Flaschen#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALSEverythingALS Radcliff Study IntroductionNeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker StudyHappy birthday Peter - July 2nd 2022Crowdsourcing: Accelerating Genetic Findings through the ALS Compute Project by Dr. John LandersVirtually bringing comfort & safety to your home
Everything ALS |

Clenbuterol for ALS: Findings from an Open Label Trial

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER